These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22534659)

  • 1. TDP-43: gumming up neurons through protein-protein and protein-RNA interactions.
    Buratti E; Baralle FE
    Trends Biochem Sci; 2012 Jun; 37(6):237-47. PubMed ID: 22534659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo.
    Scherer NM; Maurel C; Graus MS; McAlary L; Richter G; Radford RAW; Hogan A; Don EK; Lee A; Yerbury J; Francois M; Chung RS; Morsch M
    Nucleic Acids Res; 2024 May; 52(9):5301-5319. PubMed ID: 38381071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 condensation properties specify its RNA-binding and regulatory repertoire.
    Hallegger M; Chakrabarti AM; Lee FCY; Lee BL; Amalietti AG; Odeh HM; Copley KE; Rubien JD; Portz B; Kuret K; Huppertz I; Rau F; Patani R; Fawzi NL; Shorter J; Luscombe NM; Ule J
    Cell; 2021 Sep; 184(18):4680-4696.e22. PubMed ID: 34380047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Significance of TDP-43 Mutations in Disease.
    Buratti E
    Adv Genet; 2015; 91():1-53. PubMed ID: 26410029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.
    Scotter EL; Chen HJ; Shaw CE
    Neurotherapeutics; 2015 Apr; 12(2):352-63. PubMed ID: 25652699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.
    Chew J; Gendron TF; Prudencio M; Sasaguri H; Zhang YJ; Castanedes-Casey M; Lee CW; Jansen-West K; Kurti A; Murray ME; Bieniek KF; Bauer PO; Whitelaw EC; Rousseau L; Stankowski JN; Stetler C; Daughrity LM; Perkerson EA; Desaro P; Johnston A; Overstreet K; Edbauer D; Rademakers R; Boylan KB; Dickson DW; Fryer JD; Petrucelli L
    Science; 2015 Jun; 348(6239):1151-4. PubMed ID: 25977373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain.
    Budini M; Romano V; Quadri Z; Buratti E; Baralle FE
    Hum Mol Genet; 2015 Jan; 24(1):9-20. PubMed ID: 25122661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway.
    Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ; Prudencio M; Petrucelli L; Blair I; Ittner LM; Crouch PJ; Liddell JR; White AR
    Hum Mol Genet; 2017 May; 26(9):1732-1746. PubMed ID: 28334913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-Terminal Domain of ALS-Linked TDP-43 Assembles without Misfolding.
    Tsoi PS; Choi KJ; Leonard PG; Sizovs A; Moosa MM; MacKenzie KR; Ferreon JC; Ferreon ACM
    Angew Chem Int Ed Engl; 2017 Oct; 56(41):12590-12593. PubMed ID: 28833982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.
    Kao PF; Chen YR; Liu XB; DeCarli C; Seeley WW; Jin LW
    Ann Neurol; 2015 Aug; 78(2):211-21. PubMed ID: 25921485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.
    Ling SC; Polymenidou M; Cleveland DW
    Neuron; 2013 Aug; 79(3):416-38. PubMed ID: 23931993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS?
    Aulas A; Vande Velde C
    Front Cell Neurosci; 2015; 9():423. PubMed ID: 26557057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation Induces TDP-43 Mislocalization and Aggregation.
    Correia AS; Patel P; Dutta K; Julien JP
    PLoS One; 2015; 10(10):e0140248. PubMed ID: 26444430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acetylation switch controls TDP-43 function and aggregation propensity.
    Cohen TJ; Hwang AW; Restrepo CR; Yuan CX; Trojanowski JQ; Lee VM
    Nat Commun; 2015 Jan; 6():5845. PubMed ID: 25556531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
    Fang YS; Tsai KJ; Chang YJ; Kao P; Woods R; Kuo PH; Wu CC; Liao JY; Chou SC; Lin V; Jin LW; Yuan HS; Cheng IH; Tu PH; Chen YR
    Nat Commun; 2014 Sep; 5():4824. PubMed ID: 25215604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.
    Janssens J; Van Broeckhoven C
    Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing TDP-43 interaction with its RNA targets.
    Bhardwaj A; Myers MP; Buratti E; Baralle FE
    Nucleic Acids Res; 2013 May; 41(9):5062-74. PubMed ID: 23519609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins.
    Mizielinska S; Grönke S; Niccoli T; Ridler CE; Clayton EL; Devoy A; Moens T; Norona FE; Woollacott IOC; Pietrzyk J; Cleverley K; Nicoll AJ; Pickering-Brown S; Dols J; Cabecinha M; Hendrich O; Fratta P; Fisher EMC; Partridge L; Isaacs AM
    Science; 2014 Sep; 345(6201):1192-1194. PubMed ID: 25103406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting TDP-43 in neurodegenerative diseases.
    Budini M; Baralle FE; Buratti E
    Expert Opin Ther Targets; 2014 Jun; 18(6):617-32. PubMed ID: 24649927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.